InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,867.60
(
-0.80%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.27
(
0.05%
)
Bitcoin
64,213.85
(
-0.10%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Whosetosay

Send PM Follow Ignore
Followers 26
Posts 4429
Boards Moderated 0
Alias Born 06/08/2010

Whosetosay

Re: biotech_researcher post# 75774

Friday, 08/26/2016 4:38:44 PM

Friday, August 26, 2016 4:38:44 PM

Post# of 80490

I think the mentioning of starting a autoimmune trial in the future is all about putting lipstick on the pig for a sale..



Perhaps, but if it is serious, I'd stick around for it. It is a novel approach to overcoming 'immunoresistance' and actually kind of exciting. TKI is Ariad's bag, they have gotten to the point where they are good at it (finally), and some of the other 'more traditional' autoimmune approaches out there have revealed their limitations. I think it cleverest idea out of Ariad's labs since AP1903, combines Ariad's strength in TKI in the immuno mechanism paradigm, true, unique (I think, no?) 'out of the box' cutting edge kind of stuff.

The BoD overpaid themselves and the CEO, they breached their fiduciary responsibilities, they doctored their records and coerced and bought off their accuser...I want THE TRUTH!!!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up